FDA
approval
· 2022-10-31
FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Accord Healthcare Inc.)
Summary
FDA approved a supplemental application for levothyroxine sodium from Accord Healthcare Inc. under an ANDA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)